De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Cyclerion Therapeutics Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | no data |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 3.8yrs |
Recente managementupdates
Recent updates
Cyclerion stock tanks 32% on workforce reduction, clinical development refocus
Oct 06We're Keeping An Eye On Cyclerion Therapeutics' (NASDAQ:CYCN) Cash Burn Rate
Aug 09
We're Keeping An Eye On Cyclerion Therapeutics' (NASDAQ:CYCN) Cash Burn Rate
Mar 03Cyclerion Therapeutics: Distressed Spinoff Developing New Medicines For CNS Disorders
Oct 26Cyclerion Therapeutics: Insiders Buying With No Clinical Data Due Until YE 2021
Jun 21Cyclerion climbs on a series of insider purchases
Jun 08Cyclerion updates on clinical trial progress at webinar
Apr 28Who Has Been Buying Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) Shares?
Mar 09What Kind Of Shareholders Hold The Majority In Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) Shares?
Jan 28
Cyclerion Therapeutics +10.5% after prelim reports
Jan 13Cyclerion Therapeutics announces promotions
Dec 21Can You Imagine How Cyclerion Therapeutics' (NASDAQ:CYCN) Shareholders Feel About The 40% Share Price Increase?
Dec 20Cyclerion Therapeutics reports Q3 results
Nov 05CEO
Cyclerion Therapeutics heeft geen CEO, of we hebben geen gegevens over hen.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Director | 5.5yrs | US$169.80k | 15% $ 977.4k | |
| Independent Chairman | 3.5yrs | US$131.08k | 1.99% $ 129.5k | |
| Member of Scientific Advisory Board | 3.8yrs | geen gegevens | geen gegevens | |
| Independent Director | 2.3yrs | US$57.30k | 0.79% $ 51.8k | |
| Independent Director | less than a year | US$43.60k | 0.79% $ 51.8k | |
| Member of Scientific Advisory Board | 3.8yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 3.8yrs | geen gegevens | geen gegevens | |
| Chair of Scientific Advisory Board | no data | US$366.78k | geen gegevens | |
| Member of Clinical Advisory Board | 3.8yrs | geen gegevens | geen gegevens | |
| Member of Clinical Advisory Board | 3.8yrs | geen gegevens | geen gegevens | |
| Member of Clinical Advisory Board | 3.8yrs | geen gegevens | geen gegevens | |
| Member of Clinical Advisory Board | 3.8yrs | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
69yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CYCN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).